Benefit–risk assessment of vitamin D supplementation

[1]  J. Souberbielle,et al.  Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  S. Nakada,et al.  Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women , 2009, BJU international.

[3]  H. Bischoff-Ferrari,et al.  High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. , 2009, Bone.

[4]  J B Wong,et al.  Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.

[5]  S. Abrams,et al.  The effect of vitamin D2 and vitamin D3 on intestinal calcium absorption in Nigerian children with rickets. , 2009, The Journal of clinical endocrinology and metabolism.

[6]  Carlos A Camargo,et al.  Prospective Study of Serum 25‐Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All‐Cause Mortality in Older U.S. Adults , 2009, Journal of the American Geriatrics Society.

[7]  S. Boas,et al.  Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[8]  J. Tucci.  Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. , 2009, European journal of endocrinology.

[9]  D. Cole,et al.  Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. , 2009, Clinical biochemistry.

[10]  A. Peiris,et al.  The lack of vitamin D toxicity with megadose of daily ergocalciferol (D2) therapy: a case report and literature review. , 2009, Southern medical journal.

[11]  R. Koerfer,et al.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. , 2009, The American journal of clinical nutrition.

[12]  D. Kiel,et al.  Dietary Calcium and Serum 25‐Hydroxyvitamin D Status in Relation to BMD Among U.S. Adults , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  P. Calabresi,et al.  Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis , 2009, Multiple sclerosis.

[14]  R. Vieth,et al.  Long-term effects of giving nursing home residents bread fortified with 125 microg (5000 IU) vitamin D(3) per daily serving. , 2009, The American journal of clinical nutrition.

[15]  S. Titan,et al.  Acute renal failure and hypercalcemia in an athletic young man. , 2009, Clinical nephrology.

[16]  Scott M Smith,et al.  Vitamin D supplementation during Antarctic winter. , 2009, The American journal of clinical nutrition.

[17]  E John Orav,et al.  Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. , 2009, Archives of internal medicine.

[18]  J. Stoner,et al.  Finding the Optimal Dose of Vitamin D Following Roux-en-Y Gastric Bypass: A Prospective, Randomized Pilot Clinical Trial , 2009, Obesity surgery.

[19]  H. Minne,et al.  Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals , 2009, Osteoporosis International.

[20]  P. Kiely,et al.  The tolerability and biochemical effects of high‐dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency , 2009, Scandinavian journal of rheumatology.

[21]  R. Jorde,et al.  Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. , 2008, European journal of endocrinology.

[22]  Carmen L. Wiley,et al.  Vitamin D2, Vitamin D3, and the Tolerable Upper Intake Level , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  J. D. Robertson,et al.  Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium. , 2008, Arthritis and rheumatism.

[24]  A. Shao,et al.  Expanded approach to tolerable upper intake guidelines for nutrients and bioactive substances. , 2008, The Journal of nutrition.

[25]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[26]  J. D. Robertson,et al.  Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: Effect of supplementation with vitamin D and calcium , 2008, Pediatric pulmonology.

[27]  A. Scillitani,et al.  Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. , 2008, The Journal of clinical endocrinology and metabolism.

[28]  L. Byham-Gray,et al.  Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. , 2008, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[29]  D. Rousseau,et al.  The bioavailability of vitamin D from fortified cheeses and supplements is equivalent in adults. , 2008, The Journal of nutrition.

[30]  Z. Mahfoud,et al.  Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. , 2008, The Journal of clinical endocrinology and metabolism.

[31]  W. Willett,et al.  Vitamin D and Health: Perspectives From Mice and Man , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[33]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[34]  H. Taskapan,et al.  Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism , 2008, International Urology and Nephrology.

[35]  J. Aloia,et al.  Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. , 2008, The American journal of clinical nutrition.

[36]  R. Heaney,et al.  Pharmacokinetics of a single, large dose of cholecalciferol. , 2008, The American journal of clinical nutrition.

[37]  J. Binongo,et al.  Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[38]  B. Ozkan,et al.  Intragastric alendronate therapy in two infants with vitamin D intoxication: A new method , 2008, Clinical toxicology.

[39]  R. Vieth,et al.  Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men , 2008, Annals of clinical biochemistry.

[40]  J. Aloia,et al.  Dose response to vitamin D supplementation among postmenopausal African American women. , 2007, The American journal of clinical nutrition.

[41]  J. Smit,et al.  Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents , 2007, Osteoporosis International.

[42]  R. Vieth,et al.  Safety of vitamin D3 in adults with multiple sclerosis. , 2007, The American journal of clinical nutrition.

[43]  D. Acheson,et al.  Dietary supplement-induced vitamin D intoxication. , 2007, The New England journal of medicine.

[44]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. , 2007, American journal of hypertension.

[45]  Edward Giovannucci,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension , 2007, Hypertension.

[46]  E. Giovannucci,et al.  Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. , 2007, American journal of preventive medicine.

[47]  R. Newcombe,et al.  Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation , 2007, Osteoporosis International.

[48]  D. Kiel,et al.  A Higher Dose of Vitamin D Reduces the Risk of Falls in Nursing Home Residents: A Randomized, Multiple‐Dose Study , 2007, Journal of the American Geriatrics Society.

[49]  C. Wagner,et al.  High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. , 2006, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[50]  Z. Orbak,et al.  Vitamin D intoxication and therapy with alendronate (case report and review of literature) , 2006, European Journal of Pediatrics.

[51]  Richard L Prince,et al.  Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. , 2006, Archives of internal medicine.

[52]  Yan Liu,et al.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.

[53]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[54]  J. Adams,et al.  Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.

[55]  P. Drinka,et al.  Severe hypercalcemia after transition from calcium carbonate to calcium citrate in an elderly woman treated with ergocalciferol 50,000 IU per day. , 2006, The American journal of geriatric pharmacotherapy.

[56]  H. Bischoff-Ferrari,et al.  Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. , 2006, Archives of internal medicine.

[57]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[58]  G. Sigurdsson,et al.  Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. , 2005, JAMA.

[59]  R. Heaney.  The Vitamin D requirement in health and disease , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[60]  Ş. Hatun,et al.  Use of alendronate in the treatment of vitamin D intoxication in infants. , 2005, The Turkish journal of pediatrics.

[61]  R. Hoffman,et al.  Acute Vitamin D Intoxication in a Child , 2005, Pediatrics.

[62]  J. Aloia,et al.  A randomized controlled trial of vitamin D3 supplementation in African American women. , 2005, Archives of internal medicine.

[63]  C. Cooper,et al.  Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial , 2005, The Lancet.

[64]  M. Stampfer,et al.  Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. , 2004, Journal of the American Society of Nephrology : JASN.

[65]  B. Boucher,et al.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. , 2004, The American journal of clinical nutrition.

[66]  A. Sadovnick,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[67]  F. Hu,et al.  Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. , 2004, The American journal of clinical nutrition.

[68]  R. Vieth,et al.  Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients , 2004, Nutrition journal.

[69]  B. Dikici,et al.  Pamidronate treatment in acute vitamin D intoxication , 2004, Journal of endocrinological investigation.

[70]  H. Bischoff-Ferrari,et al.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. , 2004, The American journal of medicine.

[71]  C. Wagner,et al.  Assessment of dietary vitamin D requirements during pregnancy and lactation. , 2004, The American journal of clinical nutrition.

[72]  P. Hershberger,et al.  Anti-tumor activity of calcitriol: pre-clinical and clinical studies , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[73]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[74]  W. Willett,et al.  Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. , 2004, Archives of internal medicine.

[75]  Z. Krivošíková,et al.  [Intensive vitamin D supplementation in the treatment of osteoporosis]. , 2004, Vnitrni lekarstvi.

[76]  Johan Moan,et al.  Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway) , 2004, Cancer Causes & Control.

[77]  J. Yanovski,et al.  The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. , 2004, The Journal of clinical endocrinology and metabolism.

[78]  L. Dakovska,et al.  THE EFFECT OF VITAMIN D3 ON INSULIN SECRETION AND PERIPHERAL INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS , 2003, International journal of clinical practice.

[79]  Cecilia A. Hale,et al.  Calcium Absorption Varies within the Reference Range for Serum 25-Hydroxyvitamin D , 2003, Journal of the American College of Nutrition.

[80]  A. Bereket,et al.  Oral bisphosphonate therapy for vitamin D intoxication of the infant. , 2003, Pediatrics.

[81]  R. Doll,et al.  Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.

[82]  R. Lew,et al.  Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[83]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[84]  M. Schlichting,et al.  Combined Calcium and Vitamin D3 Supplementation in Elderly Women: Confirmation of Reversal of Secondary Hyperparathyroidism and Hip Fracture Risk: The Decalyos II Study , 2002, Osteoporosis International.

[85]  M. Cogswell,et al.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.

[86]  B. Dawson-Hughes,et al.  Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.

[87]  J. I. Pedersen,et al.  Can Vitamin D Supplementation Reduce the Risk of Fracture in the Elderly? A Randomized Controlled Trial , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[88]  M. M. Wong,et al.  Vitamin D poisoning by table sugar , 2002, The Lancet.

[89]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[90]  T. Chen,et al.  Vitamin D intoxication associated with an over-the-counter supplement. , 2001, The New England journal of medicine.

[91]  H. Minne,et al.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[92]  R. Vieth,et al.  Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. , 2001, The American journal of clinical nutrition.

[93]  H. Minne,et al.  Effects of a Short‐Term Vitamin D and Calcium Supplementation on Body Sway and Secondary Hyperparathyroidism in Elderly Women , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[94]  S. Cummings,et al.  Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: A longitudinal study , 1999 .

[95]  E. John,et al.  Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[96]  H. Stähelin,et al.  Calcidiol, calcitriol and parathyroid hormone serum concentrations in institutionalized and ambulatory elderly in Switzerland. , 1999, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[97]  L. Binderup,et al.  Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[98]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[99]  T. Jansen,et al.  Severe hypercalcaemia syndrome with daily low-dose vitamin D supplementation. , 1997, British journal of rheumatology.

[100]  E. B. Løken,et al.  Dietary factors and the incidence of hip fracture in middle-aged Norwegians. A prospective study. , 1997, American journal of epidemiology.

[101]  D. Felson,et al.  Relation of Dietary Intake and Serum Levels of Vitamin D to Progression of Osteoarthritis of the Knee among Participants in the Framingham Study , 1996, Annals of Internal Medicine.

[102]  L. Bouter,et al.  Falls in the elderly: a prospective study of risk factors and risk profiles. , 1996, American journal of epidemiology.

[103]  L. Bouter,et al.  Vitamin D Supplementation and Fracture Incidence in Elderly Persons , 1996, Annals of Internal Medicine.

[104]  J. S. Marks,et al.  Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate , 1995, Clinical endocrinology.

[105]  S. Blank,et al.  An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. , 1995, American journal of public health.

[106]  L. Bouter,et al.  Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. , 1995, The Journal of clinical endocrinology and metabolism.

[107]  J. Pettifor,et al.  Serum Levels of Free 1,25-Dihydroxyvitamin D in Vitamin D Toxicity , 1995, Annals of Internal Medicine.

[108]  M. Chapuy,et al.  Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women , 1994, BMJ.

[109]  F Duboeuf,et al.  Vitamin D3 and calcium to prevent hip fractures in elderly women. , 1992, The New England journal of medicine.

[110]  M. McKenna,et al.  Differences in vitamin D status between countries in young adults and the elderly. , 1992, The American journal of medicine.

[111]  I. Holm,et al.  Hypervitaminosis D associated with drinking milk. , 1992, The New England journal of medicine.

[112]  T. Clemens,et al.  Vitamin D supplementation in elderly nursing home residents increases 25(OH)D but not 1,25(OH)2D. , 1990, The American journal of clinical nutrition.

[113]  R. Honkanen,et al.  The Necessity and Safety of Calcium and Vitamin D in the Elderly , 1990, Journal of the American Geriatrics Society.

[114]  L. Lind,et al.  Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. , 1988, American journal of hypertension.

[115]  M. Holick,et al.  Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. , 1988, The Journal of clinical endocrinology and metabolism.

[116]  I. Björkhem,et al.  Lack of effects of an increased pool of 25-hydroxyvitamin D3 on urinary excretion of calcium in healthy subjects. , 1987, Contributions to nephrology.

[117]  C. Christiansen,et al.  Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. , 1986, Bone and mineral.

[118]  A. Horsman,et al.  A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. , 1985, The American journal of clinical nutrition.

[119]  J. Berry,et al.  Vitamin D metabolism in patients intoxicated with ergocalciferol. , 1985, Clinical science.

[120]  Gupta Rc,et al.  Role of vitamin D in pulmonary tuberculosis. , 1984 .

[121]  C. Christiansen,et al.  CORTICOSTEROID‐INDUCED OSTEOPENIA AND VITAMIN D METABOLISM. EFFECT OF VITAMIN D2, CALCIUM PHOSPHATE AND SODIUM FLUORIDE ADMINISTRATION , 1982, Clinical endocrinology.

[122]  S. Epstein,et al.  Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. , 1981, The Journal of clinical investigation.

[123]  B. Courvoisier,et al.  [Vitamin D intoxication]. , 1980, Schweizerische medizinische Wochenschrift.

[124]  V. Preedy,et al.  National Health and Nutrition Examination Survey , 2010 .

[125]  B. Kimler,et al.  Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer , 2009, Breast Cancer Research and Treatment.

[126]  A. Shao,et al.  Risk assessment for vitamin D. , 2007, The American journal of clinical nutrition.

[127]  P. Speiser,et al.  Pamidronate Treatment of Hypercalcemia Caused by Vitamin D Toxicity , 2007, Journal of pediatric endocrinology & metabolism : JPEM.

[128]  M. Atabek,et al.  Oral Alendronate Therapy for Severe Vitamin D Intoxication of the Infant with Nephrocalcinosis , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[129]  A. Sadeghi‐Nejad,et al.  Hypercalcemia in a Newly Arrived International Adoptee , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[130]  M. Holick,et al.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.

[131]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[132]  E. John,et al.  Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. , 1999, Cancer Epidemiology, Biomarkers and Prevention.

[133]  S. Cummings,et al.  Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group. , 1999, Arthritis and rheumatism.

[134]  R. Heaney,et al.  Vitamin D and its Major Metabolites: Serum Levels after Graded Oral Dosing in Healthy Men , 1998, Osteoporosis International.

[135]  B. Dawson-Hughes,et al.  Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. , 1997, The American journal of clinical nutrition.

[136]  A. Schwartz,et al.  Molecular biology of the calcium antagonist receptor. , 1992, Hypertension.

[137]  L. Mosekilde,et al.  Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D. , 1987, Mineral and electrolyte metabolism.

[138]  Aileen B. Sedman,et al.  A longitudinal study , 1987 .

[139]  I. Björkhem,et al.  Studies on the relationship between vitamin D3 status and urinary excretion of calcium in healthy subjects: effects of increased levels of 25-hydroxyvitamin D3. , 1986, Scandinavian journal of clinical and laboratory investigation.

[140]  N. Narang,et al.  Role of vitamin D in pulmonary tuberculosis. , 1984, The Journal of the Association of Physicians of India.